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Abstract
Background: Transfection agents comprised of cationic lipid preparations are widely used to
transfect cell lines in culture with specific recombinant complementary DNA molecules. We have
found that cells in culture are often resistant to stimulation with insulin subsequent to treatment
with transfection agents such as LipofectAMINE 2000™ and FuGENE-6™. This is seen with a
variety of different readouts, including insulin receptor signalling, glucose uptake into muscle cells,
phosphorylation of protein kinase B and reporter gene activity in a variety of different cell types
Results: We now show that this is due in part to the fact that cationic lipid agents activate the
insulin receptor fully during typical transfection experiments, which is then down-regulated. In
attempts to circumvent this problem, we investigated the effects of increasing concentrations of
LipofectAMINE 2000™ on insulin receptor phosphorylation in Chinese hamster ovary cells
expressing the human insulin receptor. In addition, the efficiency of transfection that is supported
by the same concentrations of transfection reagent was studied by using a green fluorescent protein
construct. Our data indicate that considerably lower concentrations of LipofectAMINE 2000™ can
be used than are recommended by the manufacturers. This is without sacrificing transfection
efficiency markedly and avoids the problem of reducing insulin receptor expression in the cells.
Conclusion:  Widely-used cationic lipid transfection reagents cause a state of insulin
unresponsiveness in cells in culture due to fully activating and subsequently reducing the expression
of the receptor in cells. This phenomenon can be avoided by reducing the concentration of reagent
used in the transfection process.
Background
The cell membrane represents a major barrier to the intra-
cellular delivery of macromolecules such as plasmids, oli-
gonucleotides and therapeutic proteins from outside the
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cell. Cationic lipids, such as LipofectAMINE 2000™ and
FuGENE-6™ therefore provide a useful tool for the intro-
duction of polynucleic acids into cells. Such lipids per-
form at least three functions. First, by electrostatic
association with the plasmid, the cationic lipid coats and
partially condenses the plasmid. Second, the presence of
cationic lipid at levels that give rise to an overall positive
charge leads to enhanced association of the cationic lipid/
plasmid complex with negatively charged cell surfaces,
leading to cellular uptake via endocytosis [1-3]. Third, fol-
lowing uptake, the cationic lipid plays a role in destabiliz-
ing the endosomal membrane, thus facilitating
cytoplasmic delivery of the plasmid. This is achieved
partly by destabilizing endosomal or plasma membranes
by inducing non-bilayer lipid structures in them [4,5]. In
general, the liposomes used for complex formation con-
tain at least two kinds of lipid molecules. The key compo-
nent is cationic lipid (CL) (e.g. DOTAP), which serves as
the condensing agents of the negatively charged DNA
strands. The neutral helper lipids (HL) (e.g. DOPC) are
also important, as they play a crucial role in determining
the structure of the lipid phases [6,7].
The molecular actions of insulin in cells are mediated by
the cognate insulin receptor. The insulin receptor (IR) is a
heterodimeric protein tyrosine kinase whose kinase activ-
ity is activated upon binding of insulin [8]. The kinase
activity is directed against a variety of intracellular protein
substrates, the first of which is the receptor's intracellular
domains themselves, which become phosphorylated
through autophosphorylation. As such, phosphorylation
of the IR on tyrosine residues represents the earliest stim-
ulated reaction in the insulin signal transduction cascade.
Early characterisation of the IR catalytic activity in vitro
showed that mixtures of cationic and zwitterionic lipids
activated the kinase fully [9]. Furthermore, it was
observed that lipids that tend to induce hexagonal phases
in cell membranes and liposomes increase signal trans-
duction, including IR-dependent signalling [10,11]. In
our work, we have observed that after treatment with cat-
ionic lipid transfection reagents, cells in culture are often
resistant to stimulation with insulin (unpublished obser-
vations). Thus, glucose uptake into muscle cells, activa-
tion of protein kinase B (a key mediator of insulin
signalling) and reporter gene activity in a variety of cell
lines is often no longer responsive to insulin stimulation.
We now show that this effect is in part due to the fact that
these cationic lipid reagents markedly activate the kinase
activity of the IR, leading to its subsequent down-regula-
tion. In light of the foregoing discussion, we speculate that
this is due to the formation of hexagonal phases in cell
membranes, since transfection reagents such as Lipo-
fectAMINE 2000™ have been shown to do this in cells in
culture [12]. Furthermore, we show that these phenom-
ena can be avoided if the concentration of reagent used to
transfect the cells is reduced to below that recommended
by the manufacturers, whilst maintaining acceptable lev-
els of cell transfection.
Results
Down-Regulation of Insulin Receptors by Cationic Lipid 
Reagents
We have performed various analyses in our research work
which investigate the effects of over-expression of a variety
of different proteins on insulin-mediated events in cells in
culture. Our results show that subsequent to transfection,
cells are often less responsive to insulin, irrespective of
whether the recombinant protein was expressed or not.
For example, in experiments using Chinese hamster ovary
(CHO) cells over-expressing the human insulin receptor,
protein kinase B was significantly phosphorylated on
threonine-308, which represents activation of the kinase,
in cells that were transfected with a recombinant cDNA
but left otherwise unstimulated (data not shown) We
have also examined insulin-stimulated glucose transport
in cells which express the insulin receptor endogenously
at lower levels. In these experiments (Figure 1), cells were
treated with and without LF2000 for four hours in mock
transfections, cultured a further two days and then exam-
ined for insulin-stimulated glucose transport. The data
show that in 3T3L1 mouse adipocytes, rat L6 myotubes
and SHSY5Y human neuroblastoma cells, insulin is less
able or unable to induce an increase in glucose transport
in cells that received treatment with LF2000. Thus,
LF2000 treatment of cells results in a partial or complete
reduction in insulin sensitivity that may be dependent
upon the cell type in question.
To examine the possible effects of the LF2000 transfection
reagent on IR expression and function, CHO cells express-
ing the human insulin receptor (CHO.hIR) were treated
with LF2000 for 4 hours and 24 hours and insulin recep-
tor tyrosine-phosphorylation and expression levels were
assessed. The transfection reagent FuGENE was used as a
cationic liposome control. Results showed that after 4
hours treatment with LF2000 or FuGENE, the insulin
receptor was maximally phosphorylated on tyrosine resi-
dues, equivalent to that induced by stimulation with
100nM insulin for 10 minutes (Figure 2 upper panel).
After 24 hours treatment, no receptor phosphorylation
could be detected with either LF2000 or FuGENE (Figure
2 middle panel). Furthermore when insulin receptor
expression was analysed after 24 hour treatment, we
found that IR concentrations were significantly reduced in
cells treated with either LF2000 or FuGENE compared to
resting and insulin-stimulated controls (Figure 2 lower
panel). Thus, it appears that cationic liposome transfec-
tion reagents induce a state of insulin insensitivity in cul-
tured cells through the maximal activation of the receptor
followed by its subsequent down-regulation.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/7
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Effects of LipofectAMINE 2000 reagent on insulin-stimulated glucose transport in adipocytes and muscle cells Figure 1
Effects of LipofectAMINE 2000 reagent on insulin-stimulated glucose transport in adipocytes and muscle cells.  
A) 3T3L1 preadipocytes were differentiated to adipocytes and treated with and without LF2000 as described in the methods 
section. Insulin-stimulated glucose transport was measured in replicates of six for each treatment. Data are from a single 
experiment which is representative of five such experiments that gave similar results. B) Rat L6 myocytes were differentiated 
to myotubes as described in the methods section and treated with LF2000 as above. Glucose transport was measured in a sim-
ilar manner to that for adipocytes. Data are from one experiment that has been repeated at least four times with similar 
results. C) SHSY5Y neuroblastoma cells were cultured and stimulated with insulin as described in the methods section and glu-
cose transport measured as above. Data are from one experiment performed in sextuplet, which has been repeated two fur-
ther times. **p < 0.005 with respect to no-LF2000 control; ***p < 0.0005 with respect to no-LF2000 control.
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Insulin Receptor Down-Regulation is Dose-Dependent
To investigate the dose-dependency of this effect, various
dilutions of LF2000 were made in culture medium lacking
serum, simulating the preparation of the reagent for cell
transfection, except that no recombinant cDNA was
included. Cho.hIR cells starved of serum were subse-
quently treated with the different dilutions for 4 hours
and phosphorylation of the IR was measured as described
above. Data showed that the phosphotyrosine content of
the IR increased above a threshold volume of LF2000 of 2
µl, with maximal receptor phosphorylation observed
when cells were treated with 5 µl or greater volumes of
LF2000 in medium (Figure 3). The presence of plasmid
DNA in the LF2000 dilutions did not affect the dose-
response relationship, since in the presence of pGREEN
LANTERN cDNA (9 µg), IR phosphorylation was seen to
increase in a similar fashion to that shown in Figure 3
(results not shown). Thus, the activation of the IR by
LF2000 appeared to be dependent on the dose of the
transfection reagent to which the cells were exposed.
Transfection Efficiency with Lower Doses of Cationic Lipid 
Reagent
According to the manufacturer's instructions, a recom-
mended ratio of LF2000 to cDNA is 3 µl to 1 µg. Thus,
when transfecting cells with 3 µg of any given cDNA, the
recommended amount of LF2000 to be used lies within
the range where the IR will be maximally activated. We
investigated the efficiency of transfection of Cho.hIR cells
with pGREEN LANTERN green fluorescent protein DNA
using the same range of volumes of LF2000 as were used
in the IR phosphorylation experiments. The proportion of
transfected cells was quantified using flow cytometry. The
data showed that two subpopulations of cells, which we
have termed A and B, could be distinguished in the flow
cytometer (Figure 4 upper panel), an effect that has been
reported by others previously [13,14]. These two subpop-
ulations behaved differently, with population B appar-
ently being more resistant to transfection than population
A. Nevertheless, the proportion of transfected cells
increased for both cell populations as the volume of
LF2000 used in the transfection increased (Figure 4 lower
panel). Maximal transfection of each population was
observed when volumes of LF2000 of 5 µl or greater were
used. This represents a ratio of approximately 0.6 µl
LF2000 to 1 µg cDNA, five-fold lower than that recom-
mended by the manufacturers. Furthermore, significant
rates of transfection of both cell populations were
observed when the ratio of LF2000 to cDNA was even
lower (2 µl total volume of LF2000, a ratio of 0.24 µl/µg
cDNA), where there is unlikely to be any simultaneous
activation and down-regulation of the IR.
Discussion
In this work, we have described a phenomenon of mem-
brane receptor activation by cationic lipid transfection
reagents in cells in culture, and a method by which to
avoid this, whilst retaining significant rates of cell
Cationic lipid reagents activate and down-regulate the insulin  receptor Figure 2
Cationic lipid reagents activate and down-regulate 
the insulin receptor.  Upper panel: Cho.hIR cells were 
incubated with LF2000 (Lip) or FuGENE (Fug) as described in 
the methods section or were treated with insulin (10mins) 
or medium (C). Cell lysates were blotted for phosphotyro-
sine and the position 97kDa molecular weight marker (which 
coincides with the insulin receptor beta chain) is indicated by 
the arrow. Middle panel: Cho.hIR cells were treated as above 
except that treatment with LF2000 and FuGENE lasted 24 
hours and blotted for phosphotyrosine. Lysates labelled "I" 
are from cells incubated for 24 hours as control cells and 
subsequently stimulated with insulin for 10 minutes to con-
firm that cells are otherwise responsive to insulin after the 
incubation period. The position of the 97kDa marker is indi-
cated by the arrow. Lower panel: The same cells as in the 
middle panel were blotted for the presence of the insulin 
receptor, which co-migrates with the 97kDa marker, indi-
cated by the arrow. The blots are from a representative 
experiment repeated three times.
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transfection. It was described in early experiments with
the insulin receptor that its kinase activity could be
affected by the phospholipid milieu in which it resided,
where zwitterionic lipids in particular (such as phosphati-
dylethanolamine, PE) were able to activate the kinase. A
common property of zwitterionic lipids, such as PE, is
their tendency to form hexagonal phase (HC
II) structures
in membranes rather than lamellar structures (Lα
c). Thus,
experiments reported by Lewis and Czech [9] in which the
insulin receptor kinase was fully activated in PE/PC-con-
taining liposomes, may have been due to hexagonal
phases in the vesicle membrane increasing the kinase
activity. Interestingly, Koltover and co-workers [12]
recently reported that cationic liposomes used as transfec-
tion agents comprising PE amongst others form hexago-
nal phases when complexed with DNA. This is in contrast
to liposomes containing PC where lamellar phases are
formed. Furthermore, both in prokaryotes and eukaryo-
tes, there are experimental results connecting lipids that
form hexagonal phases with altered enzyme activity in dif-
ferent membrane models, including cells over-expressing
the human insulin receptor and E. coli [10,11,15,16].
Thus, apart from the insulin receptor kinase, PC and PE
have been shown to be involved in activation of PKC iso-
forms and activation of prokaryotic diacylgycerol kinase.
Furthermore, diacylglycerol, which is also associated with
increased hexagonal phase separations in membranes,
exerts stimulatory effects on enzymes such as PKC and
phospholipase C.
Therefore, the impaired insulin signalling we have
observed in LF2000-treated cells may be coupled to the
formation of HC
II phase lipids in the cell membrane.
Potential cellular mechanisms which lead to this are
three-fold: increased autophosphorylation of the receptor
which is subsequently down-regulated; reduced sensitiv-
ity of the receptor to insulin such that it is no longer
stimulated by insulin and increased PKC activation,
LF2000 increases IR tyrosine phosphorylation in a dose-dependent fashion Figure 3
LF2000 increases IR tyrosine phosphorylation in a dose-dependent fashion.  Cho.hIR cells were treated for four 
hours with the indicated volumes of LF2000 which were previously diluted as described in the methods section. Lysates were 
blotted for phosphotyrosine and bands corresponding to the phosphorylated IR were quantified by densitometric scanning. 
Data are from one experiment performed in duplicate which was repeated with similar results three times. *p < 0.05; **p < 
0.01 compared to control. Insert: shows a typical western blot of phosphotyrosine on the insulin receptor in cells treated with 
the indicated volumes of LF2000.
LF2000 (ul)
02468 1 0
d
e
n
s
i
t
o
m
e
t
r
y
 
u
n
i
t
s
0
20000
40000
60000 **
*
00 . 51 2 51 0BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/7
Page 6 of 8
(page number not for citation purposes)
Quantification of the rates of transfection efficiency in the presence of increasing concentrations of LF2000 Figure 4
Quantification of the rates of transfection efficiency in the presence of increasing concentrations of LF2000.  
Upper panel: Flow cytometric analysis showing forward scatter against side scatter of Cho.hIR cells transfected with pGREEN 
LANTERN using 10 µl LF2000 reagent (ratio of LF2000 to cDNA of 1.1). The separation of intact cells into two subpopulations 
is indicated by the gates. Percentage values show the relative proportions of the two cell populations compared to the total 
number of events measured. Lower panel: The proportion of transfected cells in each subpopulation of Cho.hIR cells plotted 
against the volume of LF2000 reagent used. Data are the average ± S.D. from three experiments which were performed in 
duplicate for each LF2000 concentration. Filled circles, population A, open circles, population B. *p < 0.01 transfection rate in 
A> B; **p < 0.001 transfection rate in A > B.
LF2000 (ul)
02468 1 0
%
 
t
r
a
n
s
f
e
c
t
e
d
 
c
e
l
l
s
0
20
40
60
80
*
**
*BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/7
Page 7 of 8
(page number not for citation purposes)
which is associated with insulin resistance. The mem-
brane perturbations induced by LF2000, including the
formation of HC
II phases, may be involved in induction of
insulin resistance.
By using lower concentrations of LF2000 than those rec-
ommended by the manufacturer, we have shown that acti-
vation of the IR can be kept to a minimum, thereby
preserving the responsiveness of cells to insulin. Whilst
reductions of LF2000 concentrations also reduce the effi-
ciency of cell transfection, we found that over half of all
cells can be transfected when the ratio of LF2000 to cDNA
is 0.5 (volume:mass), which is considerably lower than
the ratio of 3 recommended by the manufacturers. By
reducing the ratio in this manner, the positive charge coat-
ing the cDNA is not in the same excess as is recommended
for optimal transfection. It is therefore not known
whether the rate of cell transfection we observed with
lower concentrations of LF2000 is cell type specific. Thus,
other commonly used cell lines in culture may require
higher concentrations of LF2000 to retain efficient trans-
fection rates. Such things must be worked out empirically
on a case-by-case basis. Alternative modes of transfection
can also be tested. We have recently tested polyamine-
based reagents which give acceptable levels of transfection
(Eva Danielsson, unpublished). However, it was demon-
strated a long time ago that polyamines are able to exert
insulin-like effects in fat cells through the production of
hydrogen peroxide [17]. Hydrogen peroxide is now
known to cause the reversible inhibition of protein tyro-
sine phosphatases in cells, thereby strengthening insulin
signalling. We have also shown that production of hydro-
gen peroxide chemically in cells acts as an insulin mimetic
(Liljebris et al, in the press). Thus, polyamine-based trans-
fection reagents may also activate insulin signalling, albeit
through an unrelated mechanism. It will thus be necessary
to investigate this if one intends to use polyamine-based
cell transfection in cells that are otherwise required to be
unstimulated.
Conclusions
Cationic lipid preparations are commercially available
transfection reagents that are used widely to affect the
expression of recombinant or endogenous genes in cells
in culture. Our work has shown that a common side-effect
of treatment of cells with such reagents is likely to have
been the reduced expression of the insulin receptor on the
surface of such cells with concomitant reductions in insu-
lin signalling. Apart from defining this phenomenon, our
work also shows how this can be avoided by reducing the
concentration of transfection reagent used without neces-
sarily reducing transfection rates to unacceptably low
levels.
Methods
Materials
All cell culture reagents were from Gibco. LipofectAMINE
2000™ and SDS-PAGE reagents were from Invitrogen and
FuGENE-6™ was from Roche. Hybond™-C nitrocellulose
membrane and enhanced chemiluminescence (ECL) was
from Amersham Life Science. Anti-phosphotyrosine anti-
bodies were from Santa Cruz. All other reagents were from
Sigma and were analytical grade.
Cell Culture and Treatment with Transfection Reagents
Chinese hamster ovary cells over-expressing the human
insulin receptor (CHO-hIR cells) were grown in F-12K
Nutrient Mixture (Kaighn' Modification) supplemented
with 10% heat inactivated fetal bovine serum (FBS) in 75
cm2 cell culture flasks. CHO-hIR cells were cultured at
37°C in a humidified 5% CO2 atmosphere. Two days
before treatment with LipofectAMINE™ 2000 (LF2000),
the cells were plated out in two 6-well plates. After 24
hours, cells were starved by culturing overnight in serum-
free medium. Cells were then treated in duplicate with
increasing dilutions of LF2000, which were prepared in
advance and allowed to sit at room temperature for 30
minutes. (0.5, 1, 2, 5, 10 µl diluted in 1 ml F-12K Nutrient
Mixture (Kaighn' Modification) lacking FBS). Cells were
incubated for 4 hours in 37°C in a humidified 5% CO2
atmosphere. Alternatively, cells were incubated with sin-
gle concentrations of LF2000 or FuGENE as indicated in
the figure legends. After washing, cells were lysed in 1ml
buffer comprising 20mM Hepes pH 7.6, 20% (v/v) Glyc-
erol, 10mM NaCl, 1.5mM MgCl2, 0.2mM EDTA, 0.1%
NP40 (v/v), 25mM NaF, 25mM β-glycerolphosphate,
1mM DTT, 1mM Na vanadate and protease inhibitors
(Boehringer). The cells were flash frozen in liquid nitro-
gen and then stored at -70°C until protein concentration
was determined (Bradford assay) and analysis by Western
blot. Where indicated, cells were stimulated with 100nM
insulin for the indicated periods as controls.
L6 myocytes were maintained in minimum essential
medium-alpha (α-MEM) supplemented with 10% foetal
bovine serum (FBS) and 100 IU/ml penicillin-streptomy-
cin at 37°C in 5% CO2. Cells were seeded into 96-well
plates and the medium was replaced with α MEM contain-
ing 2% FCS to induce differentiation. The medium was
changed every other day and cytidine (0.24 mg/ml
medium) was added to the cultures after a week to sus-
pend cycling cells. The cells were used in experiments after
over night serum starvation after day 10.
3T3L1 preadipocytes were cultured in DMEM/F12 con-
taining 10% serum until they became confluent. Differen-
tiation to adipocytes was achieved by sequential culture in
DMEM/F12/10% serum containing IBMX 0,5mM, IGF-I
20ng/ml, Dexamethasone 1 µM and with or without 1 µMBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/7
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Rosiglitazone for 4 days followed by DMEM/F12/10%
serum and IGF-1 alone for four days. Medium was then
reverted to culture medium and cells were used after 14
days once full differentiation was achieved.
Glucose Transport
3T3L1 cells, L6 cells and SHSY5Y cells were incubated 18
hours in serum free α-MEM supplemented with 0.25% (v/
w) fat free albumin (50 ml DMEM + 125 mg albumin).
The medium was aspirated, cells were washed with glu-
cose-free α-MEM, and the cells were incubated for 30 min-
utes in glucose-free α-MEM supplemented with 100 nM
insulin (when indicated) for 30 min. The medium was
aspirated and glucose-free α-MEM containing the tracer
was added. Glucose uptake rates were carried out for 8
minutes. The medium was aspirated and the cells were
washed twice with cold PBS. Subsequently the cells were
solubilized in 50 µl 0.5M NaOH over night at RT, scintil-
lation liquid was added (100 µl/well), plates were shaken
on the vortex at RT for 30 minutes and radioactivity was
counted in µ-Beta counter.
SDS-PAGE analysis
Samples were matched for protein concentration and
heated at 70°C for 10 minutes with 20 µl 4× concentrated
sample buffer. Samples were resolved on 4–12% gradient
gels and blotted onto nitrocellulose membranes. Mem-
branes were probed for the presence of phosphotyrosine
using a mouse monoclonal anti-phosphotyrosine anti-
body and developed using enhanced chemolumines-
cence. Phosphotyrosine content of the insulin receptor
was then quantified by densitometric analysis.
Flow cytometric analysis of green fluorescent protein 
expression
Cells were transfected with pGREEN LANTERN as above
and analysed using an EPICS® XL-MCL flow cytometer
(Beckman Coulter). For each sample, 30 000 events were
collected by list-mode data, which consisted of side scat-
ter, forward scatter, and fluorescence emissions centered
at 530 nm (FL1), 580 nm (FL2), and 610 nm (FL3).
pGREEN LANTERN-1 fluorescence occurs primarily in
FL1 but is also detectable in FL2 and FL3. However, we
chose only to present FL1 in this work. The gates were
drawn along a line of maximum detected pGREEN LAN-
TERN-1 intensity for control samples. The gates were held
unchanged through the analysis of all measurements in
all experiments.
Abbreviations
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phosphatidylcholine; PE, phosphatidylethanolamine;
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